Vertex Pharmaceuticals

Source: www.businesswire.com --- 5 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentation at the Piper Jaffray 20th Annual Health Care Conference on Tuesday, December ...

Source: www.streetinsider.com --- 19 days ago
Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/Piper+Jaffray+Initiates+Coverage+on+Vertex+Pharmaceuticals+%28VRTX%29+with+a+Buy/4150525.html for the full story. ...

Source: www.asq.org --- 19 days ago
The minimum Education Requirements is a Master's Degree with a concentration in a Scientific Discipline and 0-3 years of relevant work experience. A practical working know ...

Source: www.pmalink.org --- 10 days ago
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company?s strategy is t ...

Source: de.biz.yahoo.com --- 35 days ago
Finanzen.net - Rating-Update: Bala Cynwyd (aktiencheck.de AG) - Die Analysten von Susquehanna Financial stufen die Aktie von Vertex Pharmaceuticals (ISIN US92532F1003/ WKN 882807) von "neutral" auf "positive" hoch. (27.10.2008/ac/a/u) Analyse-Datum: 27.10.2008 ...

Source: www.reuters.com --- 28 days ago
NEW YORK (Reuters) - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show. ...

Source: www.moreover.com --- 35 days ago
CAMBRIDGE, Mass. - (Business Wire) (Nasdaq: VRTX) today reported recent clinical progress and consolidated financial results for the quarter ended September 30, 2008. ...

Source: www.moreover.com --- 35 days ago
Genetic Engineering News Oct 27 2008 8:57PM GMT ...

Source: seekingalpha.com --- 34 days ago
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2008 Earnings Call Complete Story » ...

Source: www.moreover.com --- 33 days ago
Earthtimes.org Oct 29 2008 10:54AM GMT ...

Source: www.finanztreff.de --- 32 days ago
Rating-Update:San Francisco (aktiencheck.de AG) - Die Analysten von Merriman Curhan Ford & Co stufen die Aktie von Vertex Pharmaceuticals (ISIN US92532F1003/ WKN 882807) in einer Ersteinschätzung mit ... ...

Source: www.cen-chemjobs.org --- 40 days ago
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Companyâ¬"s strategy is ...

Source: www.finanznachrichten.de --- 32 days ago
Rating-Update: San Francisco (aktiencheck.de AG) - Die Analysten von Merriman Curhan Ford & Co stufen die Aktie von Vertex Pharmaceuticals (ISIN ... ...

Source: www.schaeffersresearch.com --- 61 days ago
Given everything that is going on in the market, I thought it might be interesting to see what stocks are leading this year...( Read More ) ...

Source: www.bloggingstocks.com --- 24 days ago
Filed under: Newsletters , Mutual funds , Presidential elections , Commodities , Oil , Agriculture , Stocks to Buy , Green Stocks , Obama Picks What sectors are poised to outperform as a result of a Barack Obama presidency? To find out, we turn to fund expert Jim Lowell who recent prepared a report highlighting the top ETFs based on each candidate. In The Forbes ETF Trader , he offers several top picks including ETFs that are focused on biotechnology and medical research, industrials, clean environment and clean energy technologies. " SPDR Biotech (ASE: XBI ) seeks investment results that correspond to the price and yield performance of the S&P Biotechnology Select Industry Index which is made up of the biotechnology sector of the S&P Total Markets Index. "It began trading in January 2006. The top ten holdings are Genentech, Amgen, Gilead Sciences, Celgene, Genzyme, Biogen Idec, Imclone, Cephalon, Vertex Pharmaceuticals, and Alexion Pharmaceuticals. " Vanguard Industrials (NYSE: VIS ) seeks investment results that correspond to the price and yield performance of the Morgan Stanley Capital International US Investable Market Industrials Index. Continue reading Obama Picks: Fund expert's top ETFs Obama Picks: Fund expert's top ETFs originally appeared on BloggingStocks on Wed, 05 Nov 2008 14:00:00 EST. Please see our terms for use of feeds . Permalink  |  Email this  |  Comments ...

Source: www.centredaily.com --- 29 days ago
New clinical data from four Phase 2 clinical trials of the investigational hepatitis C protease inhibitor telaprevir (VX-950) to be presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco support a broad profile for telaprevir in the treatment of chronic genotype 1 hepatitis C virus infection. Telaprevir is being developed by Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) in collaboration with Tibotec. ...

Source: www.asq.org --- 61 days ago
Description: Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecul ...

Source: www.xconomy.com --- 28 days ago
More data is rolling in from Vertex Pharmaceuticals on its lead drug for hepatitis C, and it looks like the medicine is continuing to live up to its own high expectations. The Cambridge, MA-based company said today that telaprevir’s effect on killing the virus is remaining durable on follow-up analysis, and the drug appears to [...] ...

Source: www.asq.org --- 47 days ago
Qualifications: A Ph.D. or Master's degree in the life sciences with a preference for a concentration in Chemistry, Pharmaceutical Sciences or Chemical Engineering ...

Source: www.topix.com --- 40 days ago
Vertex Pharmaceuticals Incorporated today announced positive results from a preliminary analysis of data from Part 2 of the Phase 2a clinical trial of the investigational oral drug VX-770 in cystic fibrosis ... ...